Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

about

Medication overuse headache following repeated morphine, but not [INCREMENT]9-tetrahydrocannabinol administration in the female rat.Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice.Emerging Role of (Endo)Cannabinoids in Migraine.

P2860

Q52315641-CA3B9919-77FB-440F-A5AD-B6F4A9B5C11D Q52660821-FBF612BF-AACF-490C-9970-BFAE6E2CA62E Q55280787-08C1DC90-1991-4FCE-B6EC-B02E89C736AB

P2860

Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

Item

http://www.wikidata.org/entity/Q47587769

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

@en

Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

@nl

type

Item

label

Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

@en

Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

@nl

prefLabel

Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

@en

Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

@nl

P1476

Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat

@en

P2093

Cole T Dawson

http://www.w3.org/2001/XMLSchema#string

Michael M Morgan

http://www.w3.org/2001/XMLSchema#string

Rebecca M Craft

http://www.w3.org/2001/XMLSchema#string

P2860

Sex differences in the epidemiology, clinical features, and pathophysiology of migraine.

Home cage wheel running is an objective and clinically relevant method to assess inflammatory pain in male and female rats

Depression of home cage wheel running: a reliable and clinically relevant method to assess migraine pain in rats.

Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.

SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.

New therapeutic approaches for the prevention and treatment of migraine.

Effect of cannabinoid receptor activation on spreading depression.

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system.

Activation of TRPA1 on dural afferents: a potential mechanism of headache pain.

New drugs for migraine

P304

271-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJPHAR.2017.10.054

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

818

http://www.w3.org/2001/XMLSchema#string

P50

Ram Kandasamy

P577

2017-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29111112

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

tetrahydrocannabinol

cannabinoids

P932

5742305

http://www.w3.org/2001/XMLSchema#string

Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

about

P2860

P2860

Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932